By Adam C. Fox, Senior Vice President, Analytical Operations, Nitto Avecia Pharma Services
Many new delivery systems and drug-device combinations make dosing less cumbersome for patients and healthcare providers. But they add more complexity for drug developers.
Traditionally viewed as isolated subassemblies, container/closure systems today are essential to achieving therapeutic value.
Read how Nitto Avecia Pharma Services develops and validates new methodologies to support the latest in container/closure systems as well as traditional designs. It specializes in testing injectable products.